Opinion|Videos|December 16, 2025

Dose Reducing and Sequencing Therapies in Desmoid Tumors

Experts discuss dose reduction strategies and emerging therapies for desmoid tumors, emphasizing patient monitoring and quality of life improvements.

Panelists discuss the questions below in this video.

  • When is it appropriate to dose reduce with nirogacestat and how can this ensure the desired clinical outcomes are met?
  • How are you sequencing therapies in your institution?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo